Signal transduction by bone morphogenetic proteins

Urist, 1965, Science, 150, 893, 10.1126/science.150.3698.893 Wozney, 1988, Science, 242, 1528, 10.1126/science.3201241 Reddi AH. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 1997, 8, 11–20. Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10, 1580–1594. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994, 8, 133–146. Sampath, 1993, Proc Natl Acad Sci USA, 90, 6004, 10.1073/pnas.90.13.6004 Padgett, 1993, Proc Natl Acad Sci USA, 90, 2905, 10.1073/pnas.90.7.2905 Winnier G, Blessing M, Labosky PA, Hogan BLM. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995, 9, 2105–2116. Zhang H, Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122, 2977–2986. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995, 9, 2795–2807. Luo G, Hofmann C, Bronckers ALJJ, Sohocki M, Bradley, A, Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995, 9, 2808–2820. Zhao G-Q, Deng K, Labosky PA, Liaw L, Hogan BLM. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev 1996, 10, 1657–1669. Kingsley, 1992, Cell, 71, 399, 10.1016/0092-8674(92)90510-J Staehling-Hampton, 1994, Cell, 5, 585 Storm, 1994, Nature, 368, 639, 10.1038/368639a0 Chang, 1994, J Biol Chem, 269, 28227, 10.1016/S0021-9258(18)46918-9 Wolfman, 1997, Clin Invest, 100, 321, 10.1172/JCI119537 Hötten GC, Matsumoto T, Kimura M, Bechtold RF, Kron R, Ohara T, Tanaka H, Satoh Y, Okazaki M, Shirai T, Pan H, Kawai S, Pohl JS, Kudo A. Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors 1996, 13, 65–74. Thomas JT, Lin K, Nandedkar M, Camargo M, Cervenka J, Luyten FP. A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nat Genet 1996, 12, 315–317. Thomas JT, Kilpatrick MW, Lin K, Erlacher L, Lembessis P, Costa T, Tsipouras P, Luyten FP. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat Genet 1997, 17, 58–64. Polinkovsky A, Robin NH, Thomas JT, Irons M, Lynn A, Goodman FR, Reardon W, Kant SG, Brunner HG, van der Burgt I, Chitayat D, McGaughran J, Donnai D, Luyten FP, Warman ML. Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat Genet 1997, 17, 18–19. McPherron, 1997, Nature, 387, 83, 10.1038/387083a0 Grobet L, Royo Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Menissier F, Massabanda J, Fries R, Hanset R, Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 1997, 17, 71–74. Dong, 1996, Nature, 383, 531, 10.1038/383531a0 Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, Tsukuda R, Sasaki S, Fujisawa Y. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun 1995, 210, 670–677. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA, Wozney JM. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 1996, 13, 291–300. Arora K, Levine MS, O’Connor MB. The screw gene encodes a ubiquitously expressed member of the TGF-β family required for specification of dorsal cell fates in the Drosophila embryo. Genes Dev 1994, 8, 2588–2601. Zimmerman, 1996, Cell, 86, 599, 10.1016/S0092-8674(00)80133-6 Piccolo, 1996, Cell, 86, 589, 10.1016/S0092-8674(00)80132-4 Yamashita, 1995, J Cell Biol, 130, 217, 10.1083/jcb.130.1.217 Fainsod A, Deissler K, Yelin R, Marom K, Epstein M, Pillemer G, Steinbeisser H, Blum M. The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4. Mech Dev 1997, 63, 39–50. Matzuk, 1995, Nature, 374, 360, 10.1038/374360a0 Dijke, 1996, Cell, 8, 139 Wrana, 1994, Nature, 370, 341, 10.1038/370341a0 Wieser R, Wrana JL, Massagué J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 1995, 14, 2199–2208. Okadome, 1996, J Biol Chem, 271, 21687, 10.1074/jbc.271.36.21687 Charng, 1996, J Biol Chem, 271, 22941, 10.1074/jbc.271.38.22941 Wang, 1996, Cell, 86, 435, 10.1016/S0092-8674(00)80116-6 Chen YG, Liu F, Massagué J. Mechanisms of TGFβ receptor inhibition by FKBP12. EMBO J 1997, 16, 3866–3876. Rosenzweig, 1995, Proc Natl Acad Sci USA, 92, 7632, 10.1073/pnas.92.17.7632 Nohno, 1995, J Biol Chem, 270, 22522, 10.1074/jbc.270.38.22522 Kawabata, 1995, J Biol Chem, 270, 5625, 10.1074/jbc.270.10.5625 Liu, 1995, Cell, 15, 3479 Beppu H, Minowa O, Miyazono K, Kawabata M. cDNA cloning and genomic organization of the mouse BMP type II receptor. Biochem Biophys Res Commun 1997, 235, 499–504. Ishikawa T, Yoshioka H, Ohuchi H, Noji S, Nohno T. Truncated type II receptor for BMP-4 induces secondary axial structures in Xenopus embryos. Biochem Biophys Res Commun 1995, 216, 26–33. Nishitoh, 1996, J Biol Chem, 271, 21345, 10.1074/jbc.271.5.2769 Hoodless, 1996, Cell, 85, 489, 10.1016/S0092-8674(00)81250-7 Demetriou, 1996, J Biol Chem, 271, 12755, 10.1074/jbc.271.22.12755 Matzuk, 1995, Nature, 374, 356, 10.1038/374356a0 Oh SP, Li E. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev 1997, 11, 1812–1826. Matzuk, 1995, Nature, 374, 354, 10.1038/374354a0 Childs, 1993, Proc Natl Acad Sci USA, 90, 9475, 10.1073/pnas.90.20.9475 Ruberte, 1995, Cell, 80, 889, 10.1016/0092-8674(95)90292-9 Letsou, 1995, Cell, 80, 899, 10.1016/0092-8674(95)90293-7 Dijke, 1994, J Biol Chem, 269, 16985, 10.1016/S0021-9258(17)32506-1 Koenig, 1994, Cell, 14, 5961 Suzuki, 1994, Proc Natl Acad Sci USA, 91, 10255, 10.1073/pnas.91.22.10255 Imamura, 1997, Nature, 389, 622, 10.1038/39355 Namiki, 1997, J Biol Chem, 272, 22046, 10.1074/jbc.272.35.22046 Dewulf N, Verschueren K, Lonnoy O, Morén A, Grimsby S, Vande Spiegle K, Miyazono K, Huylebroeck D, ten Dijke P. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 1995, 136, 2652–2663. Yamada, 1996, Cancer, 73, 624, 10.1038/bjc.1996.108 Penton, 1994, Cell, 78, 239, 10.1016/0092-8674(94)90294-1 Brummel, 1994, Cell, 78, 251, 10.1016/0092-8674(94)90295-X Muramatsu, 1997, Cell, 8, 469 Persson, 1997, J Biol Chem, 272, 21187, 10.1074/jbc.272.34.21187 Lin, 1995, J Biol Chem, 270, 2747, 10.1074/jbc.270.6.2747 Natsume, 1997, J Biol Chem, 272, 11535, 10.1074/jbc.272.17.11535 Graff, 1994, Cell, 79, 169, 10.1016/0092-8674(94)90409-X Zou, 1996, Science, 272, 738, 10.1126/science.272.5262.738 Yokouchi Y, Sakiyama J, Kameda T, Iba H, Suzuki A, Ueno N, Kuroiwa A. BMP-2/-4 mediate programmed cell death in chicken limb buds. Development 1996, 122, 3725–3734. Mishina Y, Suzuki A, Ueno N, Behringer RR. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995, 9, 3027–3037. Nellen, 1994, Cell, 78, 225, 10.1016/0092-8674(94)90293-3 Feng X-H, Derynck R. A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling specificity. EMBO J 1997, 16, 3912–3923. Yamaguchi, 1995, Science, 270, 2008, 10.1126/science.270.5244.2008 Raftery, 1995, Genetics, 139, 241, 10.1093/genetics/139.1.241 Sekelsky, 1995, Genetics, 139, 1347, 10.1093/genetics/139.3.1347 Savage, 1996, Proc Natl Acad Sci USA, 93, 790, 10.1073/pnas.93.2.790 Newfeld SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-β responsive cells. Development 1996, 122, 2099–2018. Wiersdorff V, Lecuit T, Cohen SM, Mlodzik M. Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. Development 1996, 122, 2153–2162. Derynck, 1996, Cell, 87, 173, 10.1016/S0092-8674(00)81335-5 Hahn, 1996, Science, 271, 350, 10.1126/science.271.5247.350 Baker JC, Harland RM. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 1996, 10, 1880–1889. Macías-Silva, 1996, Cell, 87, 1215, 10.1016/S0092-8674(00)81817-6 Souchelnytski, 1997, J Biol Chem, 272, 28107, 10.1074/jbc.272.44.28107 Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 1997, 11, 984–995. Wilson PA, Lagna G, Suzuki A, Hemmati-Brivanlou A. Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1. Development 1997, 124, 3177–3184. Suzuki A, Chang C, Yingling JM, Wang X-F, Hemmati-Brivanlou A. Smad5 induces ventral fates in Xenopus embryo. Dev Biol 1997, 184, 402–405. Watanabe TK, Suzuki M, Omori Y, Hishigaki H, Horie M, Kanemoto N, Fujiwara T, Nakamura Y, Takahasi E. Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics 1997, 42, 446–451. Eppert, 1996, Cell, 86, 543, 10.1016/S0092-8674(00)80128-2 Zhang, 1996, Nature, 383, 168, 10.1038/383168a0 Lagna, 1996, Nature, 383, 832, 10.1038/383832a0 Hayashi, 1997, Cell, 89, 1165, 10.1016/S0092-8674(00)80303-7 Nakao, 1997, Nature, 389, 631, 10.1038/39369 Tsuneizumi, 1997, Nature, 389, 627, 10.1038/39362 Graff, 1996, Cell, 85, 479, 10.1016/S0092-8674(00)81249-0 Thomsen GH. Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 1996, 122, 2359–2366. Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr Biol 1997, 7, 270–276. Liu, 1996, Nature, 381, 620, 10.1038/381620a0 Shi, 1997, Nature, 388, 87, 10.1038/40431 Hata, 1997, Nature, 388, 82, 10.1038/40424 Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J-i, Heldin C-H, Miyazono K, ten Dijke P. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997, 16, 5353–5362. Newfeld SJ, Mehra A, Singer MA, Wrana JL, Attisano L, Gelbart WM. Mothers against dpp participates in a DPP/TGF-β responsive serine-threonine kinase signal transduction cascade. Development 1997, 124, 3167–3176. Wu, 1997, Cell, 17, 2521 Caestecker, 1997, J Biol Chem, 272, 13690, 10.1074/jbc.272.21.13690 Keeton, 1991, J Biol Chem, 266, 23048, 10.1016/S0021-9258(18)54461-6 Li J-M, Nichols MA, Chandrasekharan S, Xiong Y, Wang X-F. Transforming growth factor β activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J Biol Chem 1995, 270, 26750– 26753. Datto, 1995, J Biol Chem, 270, 28623, 10.1074/jbc.270.48.28623 Watabe T, Kim S, Candia A, Rothbacher U, Hashimoto C, Inoue K, Cho KW. Molecular mechanisms of Spemann’s organizer formation: conserved growth factor synergy between Xenopus and mouse. Genes Dev 1995, 9, 3038–3050. Harada S-i, Sampath TK, Aubin JE, Rodan GA. Osteogenic protein-1 upregulation of the collagen X promoter activity is mediated by a MEF-2 like sequence and requires an adjacent AP-1 sequence. Mol Endocrinol 1997, 11, 1832–1845. Chen, 1996, Nature, 383, 691, 10.1038/383691a0 Chen, 1997, Nature, 389, 85, 10.1038/38008 Kim, 1997, Nature, 388, 304, 10.1038/40906 Arora, 1995, Cell, 81, 781, 10.1016/0092-8674(95)90539-1 Grieder, 1995, Cell, 81, 791, 10.1016/0092-8674(95)90540-5 Staehling-Hampton K, Laughon AS, Hoffmann FM. A Drosophila protein related to the human zinc finger transcription factor PRDII/MBPI/HIV-EP1 is required for dpp signaling. Development 1995, 121, 3393–3403. Topper, 1997, Proc Natl Acad Sci USA, 94, 9314, 10.1073/pnas.94.17.9314 Oshima M, Oshima H, Taketo MM. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996, 179, 297–302. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR. Genetic analysis of the Müllerian- inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 1996, 10, 2577–2587. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996, 13, 189–195.